医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Skin Garden: Demand for Korean Brand Moisturizers Is Growing at Remarkable Rate in Tokyo

2015年09月24日 PM12:23
このエントリーをはてなブックマークに追加


 

TOKYO

Skin Garden (http://www.skingarden.jp/), a K-cosmetics shop located in the central area of the Korean wave shopping district in Shinjuku, Tokyo, announced that the sales of moisturizing products have increased remarkably.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150923006380/en/

Skin Garden, a K-cosmetics shop located in the central area of the Korean wave shopping district in  ...

Skin Garden, a K-cosmetics shop located in the central area of the Korean wave shopping district in Shinjuku, Tokyo (Photo: Business Wire)

This is because Japanese customers are queuing up for Korean brand moisturizers to care for their skin that has become dry due to change of the season.

“Recently, the sales of Skin Garden ‘Hydro-gel Eye Patch’ and ‘Soothing Moisture Gel,’ which are Skin Garden’s PB brands, and Korean cosmetics brands’ mask sheets and moisturizing skin care products have increased sharply,” said an insider of Skin Garden, a leading Hallyu cosmetics shop in Japan. “The technological power of Korean cosmetics providing rich nourishment and moisturizing effect at a reasonable price range must have been a key to capturing the heart of meticulous Japanese consumers.”

Offering a wide range of trendy items at reasonable prices, Skin Garden, a K-beauty select shop, is much loved by Japanese consumers.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150923006380/en/

CONTACT

Skin Garden
Youngun Park, +82 70-8768-7946
park98@skingarden.jp

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform